|
|
|
|
Comera Life Sciences Holdings Inc (NASDAQ: CMRA) |
|
|
|
| |
CMRA's Revenue Growth by Quarter and Year
Comera Life Sciences Holdings Inc 's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| CMRA Revenue (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
| IV Quarter |
December |
-
|
0.25
|
0.00
|
0.00
|
| III Quarter |
September |
0.14
|
0.23
|
0.00
|
0.00
|
| II Quarter |
June |
0.32
|
0.15
|
0.00
|
0.00
|
| I Quarter |
March |
0.39
|
0.00
|
0.00
|
0.00
|
| FY |
|
0.85
|
0.63
|
0.00
|
0.00
|
| CMRA Revenue third quarter 2023 Y/Y Growth Comment |
Comera Life Sciences Holdings Inc reported fall in Revenue in the third quarter 2023 by -40.73% to $ 0.14 millions, from the same quarter in 2022.
The drop in the third quarter 2023 Comera Life Sciences Holdings Inc 's Revenue compares unfavorably to the Company's average Revenue rise of 36.37%.
Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 202 other companies have achieved higher Revenue growth. While Comera Life Sciences Holdings Inc ' s Revenue drop of -40.73% ranks overall at the positon no. 3645 in the third quarter 2023.
|
| CMRA Revenue ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
- |
- |
- |
| III Quarter |
September |
-40.73 % |
- |
- |
- |
| II Quarter |
June |
113.33 % |
- |
- |
- |
| I Quarter |
March |
- |
- |
- |
- |
| FY |
|
- |
- |
- |
- |
CMRA Revenue (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
8.7 % |
- |
- |
| III Quarter |
September |
-57.4 % |
53.33 % |
- |
- |
| II Quarter |
June |
-17.95 % |
- |
- |
- |
| I Quarter |
March |
56 % |
- |
- |
- |
| FY (Year on Year) |
|
- |
- |
- |
- |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 114.72 % |
36.37 % |
-41.98 % |
| (Jun 30 2023) |
|
(Sep 30 2023) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 114.72 % |
36.37 % |
-41.98 % |
| (Jun 30 2023) |
|
(Sep 30 2023) |
|
| Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Comera Life Sciences Holdings Inc 's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 60.11 % |
9.37 % |
-56.73 % |
| (Sep 30 2022) |
|
|
| CMRA's III. Quarter Q/Q Revenue Comment |
In the III. Quarter 2023 Comera Life Sciences Holdings Inc reported fall in Revenue from the previous quarter by -57.4% to $ 0.14 millions, from $ 0.32 millions achived a quarter before.
Even periodic factors that commonly fuel III. Quarter 2023 Revenue, were not able to recover the III. Quarter for the Comera Life Sciences Holdings Inc , Most analysts said, he mentioned some caution for the Comera Life Sciences Holdings Inc 's direction.
Within Major Pharmaceutical Preparations industry 214 other companies have achieved higher Revenue quarter on quarter growth. While Comera Life Sciences Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3392. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 60.11 % |
9.37 % |
-56.73 % |
| (Sep 30 2022) |
|
|
| CMRA's III. Quarter Q/Q Revenue Comment |
In the III. Quarter 2023 Comera Life Sciences Holdings Inc reported fall in Revenue sequentially by -57.4% to $ 0.14 millions, from $ 0.32 millions achived a quarter before.
Some periodic circumstance have not salvage the III. Quarter for the Comera Life Sciences Holdings Inc , Most analysts pointed out, he sees further difficulties onward for CMRA and continued that average quarter on quarter Revenue growth is at 9.37% for CMRA.
Within Major Pharmaceutical Preparations industry 214 other companies have achieved higher Revenue quarter on quarter growth. While Comera Life Sciences Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3392. |
|
Comera Life Sciences Holdings Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
| Cumulative Revenue 12 Months Ending |
$ 1.10 |
$ 1.19 |
$ 1.03 |
$ 0.00 |
$ 0.00 |
| Y / Y Revenue Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year Revenue Growth Overall
Ranking |
# |
# |
# |
# |
# |
| Seqeuential Revenue Change (TTM) |
-8.26 % |
16.41 % |
- |
- |
- |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 1007 |
# 1169 |
# 0 |
# 0 |
# 0 |
| Cumulative Revenue growth
Comment |
Comera Life Sciences Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. . |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 98 |
| Sector |
# 228 |
| S&P 500 |
# 1007 |
|
| Cumulative Revenue growth
Comment |
Comera Life Sciences Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. . |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 98 |
| Sector |
# 228 |
| S&P 500 |
# 1007 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
